Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)

Inclusion Criteria

• •HeartMate II Left Ventricular Assist Device (LVAD) patient
• •Patient has signed an informed consent for data collection.
• •Patient was discharged, or is being discharged, from the hospital after their initial LVAD implant surgery.
• •Patient:
• •* at time of enrolling in study, is currently on, with the intention of being maintained on reduced anti-thrombotic therapy (RT) for chronic long-term management.
• •OR
• •\-- On or after January 1, 2011 patient was being maintained on, or had been initiated with the intention of being maintained on, reduced anti-thrombotic therapy (RT) for chronic long-term management; but where RT was subsequently discontinued due to an adverse event or transplant, explant, or death.